» Articles » PMID: 37324227

[Ga] Ga-Pentixafor Diffuse Bilateral Adrenal & Breast Uptake in a Patient with High-grade Glioma: A Note of Caution on Normal Variants

Overview
Specialty Nuclear Medicine
Date 2023 Jun 16
PMID 37324227
Authors
Affiliations
Soon will be listed here.
Abstract

[Ga] Ga-labeled C-X-C motif receptor4 as a novel radio-ligand using PET/CT has been investigated for tracing various kinds of solid and hematopoietic malignancies in recent years. High-grade Glioma (WHO classification 2016 grade III and IV) shows elevated levels of CXCR4 ligand expression in the affected tumoral cells. Healthy and non-affected organ cells express low-level CXCR4 ligands density. We performed [Ga] Ga-Pentixafor (Pars-Cixafor™) PET/CT in a patient with high-grade Glioma (anaplastic oligodendroglioma WHO grade III) with no other documented medical condition and history. In addition to the Pentixafor-avid tumor remnant in the PET/CT images, we observed mild symmetrical bilateral uptake in the fibro glandular tissue of the breasts and moderate CXCR4(Pentixafor) avidity in both adrenal glands without any discernable pathology and abnormal density changes in the CT component of the study. Attention should be paid to the interpreting [Ga] Ga-Pentixafor PET/CT examination and its normal uptakes and variants.

References
1.
Laird S, Widdowson R, El-Sheikhi M, Hall A, Li T . Expression of CXCL12 and CXCR4 in human endometrium; effects of CXCL12 on MMP production by human endometrial cells. Hum Reprod. 2011; 26(5):1144-52. DOI: 10.1093/humrep/der043. View

2.
Ding J, Zhang Y, Wen J, Zhang H, Wang H, Luo Y . Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur J Nucl Med Mol Imaging. 2020; 47(11):2656-2665. DOI: 10.1007/s00259-020-04722-0. View

3.
Lapa C, Luckerath K, Kleinlein I, Monoranu C, Linsenmann T, Kessler A . (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma. Theranostics. 2016; 6(3):428-34. PMC: 4737728. DOI: 10.7150/thno.13986. View

4.
Vag T, Steiger K, Rossmann A, Keller U, Noske A, Herhaus P . PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma. EJNMMI Res. 2018; 8(1):90. PMC: 6127070. DOI: 10.1186/s13550-018-0442-0. View

5.
Heinze B, Fuss C, Mulatero P, Beuschlein F, Reincke M, Mustafa M . Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma. Hypertension. 2017; 71(2):317-325. DOI: 10.1161/HYPERTENSIONAHA.117.09975. View